| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Michael W Russell | |
| P2860 | cites work | Mucosal immune system of the human genital tract | Q33547159 |
| Generation of female genital tract antibody responses by local or central (common) mucosal immunization | Q33591251 | ||
| Evaluation of immunoglobulin A1 (IgA1) protease and IgA1 protease-inhibitory activity in human female genital infection with Neisseria gonorrhoeae | Q33769074 | ||
| Limited local and systemic antibody responses to Neisseria gonorrhoeae during uncomplicated genital infections | Q34001388 | ||
| Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb | Q34003066 | ||
| Recombinant antigen-enterotoxin A2/B chimeric mucosal immunogens differentially enhance antibody responses and B7-dependent costimulation of CD4(+) T cells | Q34005585 | ||
| Induction of mucosal immunity by intranasal application of a streptococcal surface protein antigen with the cholera toxin B subunit | Q34522325 | ||
| Humoral immune responses to microbial infections in the genital tract | Q34669747 | ||
| Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant | Q35476128 | ||
| Induction of specific immunoglobulin A in the small intestine, colon-rectum, and vagina measured by a new method for collection of secretions from local mucosal surfaces | Q35770690 | ||
| Unique CD8+ T cell-rich lymphoid aggregates in human uterine endometrium. | Q36853996 | ||
| Cytokine and antibody responses in women infected with Neisseria gonorrhoeae: effects of concomitant infections | Q37880294 | ||
| Normal uterine cervix: characterization of isolated lymphocyte phenotypes and immunoglobulin secretion | Q38290778 | ||
| Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus | Q45771831 | ||
| Long-term persistence and recall of immune responses in aged mice after mucosal immunization. | Q52019712 | ||
| Current options for vaccine delivery systems by mucosal routes | Q57069696 | ||
| Distribution of lymphocytes and adhesion molecules in human cervix and vagina | Q62638937 | ||
| A comparison of antibody titres in mouse uterine fluid after immunization by several routes, and the effect of the uterus on antibody titres in vaginal fluid | Q68922624 | ||
| Local intravaginal vaccination of the female genital tract | Q71623449 | ||
| Human circulating specific antibody-forming cells after systemic and mucosal immunizations: differential homing commitments and cell surface differentiation markers | Q71677072 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunization | Q1415366 |
| P304 | page(s) | 265-268 | |
| P577 | publication date | 2002-05-01 | |
| P1433 | published in | American Journal of Reproductive Immunology | Q15761228 |
| P1476 | title | Immunization for protection of the reproductive tract: a review | |
| P478 | volume | 47 |
| Q36135698 | A Probiotic Adjuvant Lactobacillus rhamnosus Enhances Specific Immune Responses after Ocular Mucosal Immunization with Chlamydial Polymorphic Membrane Protein C. |
| Q35871689 | A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challenge |
| Q28476693 | A novel strategy for inducing enhanced mucosal HIV-1 antibody responses in an anti-inflammatory environment |
| Q51449118 | CD4⁺ T-cell immunity in the female genital tract is critically dependent on local mucosal immunization. |
| Q36555158 | Current trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2. |
| Q34524955 | Evaluation of TLR agonists as potential mucosal adjuvants for HIV gp140 and tetanus toxoid in mice |
| Q46308392 | Immunization without needles |
| Q36028197 | Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine |
| Q80607729 | Molecular adjuvant C3d3 improved the anti-hCGbeta humoral immune response in vaginal inoculation with live recombinant Lactobacillus expressing hCGbeta-C3d3 fusion protein |
| Q34648207 | Mucosal administration of CpG oligodeoxynucleotide elicits strong CC and CXC chemokine responses in the vagina and serves as a potent Th1-tilting adjuvant for recombinant gD2 protein vaccination against genital herpes |
| Q37427432 | Mucosal and cellular immune responses elicited by recombinant Lactococcus lactis strains expressing tetanus toxin fragment C. |
| Q81312029 | Mucosal delivery of CpG oligodeoxynucleotides expands functional dendritic cells and macrophages in the vagina |
| Q36520832 | Mucosal herpes immunity and immunopathology to ocular and genital herpes simplex virus infections |
| Q51823909 | Mucosal inoculation of Lactobacillus expressing hCGbeta induces an anti-hCGbeta antibody response in mice of different strains. |
| Q37384857 | New concepts in herpes simplex virus vaccine development: notes from the battlefield |
| Q33209363 | Potential and opportunities for use of recombinant lactic acid bacteria in human health |
| Q34663077 | Protein-coated nanoparticles are internalized by the epithelial cells of the female reproductive tract and induce systemic and mucosal immune responses |
| Q44567172 | Systemic and mucosal antibody responses following retroductal gene transfer to the salivary gland |
| Q33930469 | Unraveling molecular signatures of immunostimulatory adjuvants in the female genital tract through systems biology |
Search more.